FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
HAWES GEORGE T
   2. Issuer Name and Ticker or Trading Symbol
ORAGENICS INC [oni] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O PROGINET CORPORATION, 200 GARDEN CITY PLAZA, SUITE 220		 3. Date of Earliest Transaction (Month/Day/Year)
01/11/2008
(Street)

GARDEN CITY, NY 11530		 4. If Amendment, Date Original Filed(Month/Day/Year)
08/09/2007		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
warrants (1) $ 0.44 01/11/2008(1)   P   587,500 (1)   01/11/2008(1) 02/08/2008 common stock 587,500 $ 0 587,500 D  
warrants $ 0.44 (2) 01/28/2008(2)   P   1,000,000 (2)   01/28/2008(2) 08/08/2008 common stock 1,000,000 $ 0 1,000,000 D  
Non-employee Director Options $ 0.74             09/08/2006 09/08/2011 common stock 65,000   65,000 D  
warrants $ 0.44 (3) 01/28/2008(3)   P   100,000 (4)   01/28/2008(3) 08/08/2008 common stock 100,000 (4) $ 0 100,000 (4) I By wife

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
HAWES GEORGE T
C/O PROGINET CORPORATION
200 GARDEN CITY PLAZA, SUITE 220
GARDEN CITY, NY 11530		   X   X    

Signatures

 George Hawes by Daniel H. Luciano atty-in-fact   01/31/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These warrants were orginally issued to the Reporting Person on March 6, 2006 at an exercise price of $0.60 per share. On January 11, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period fron January 11, 2008 to February 8, 2008, which is the expiration date.
(2) These warrants were originally issued to the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 during the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 per share during the remainder of the warrant term.
(3) These warrants were originally issued to the spouse of the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 for the remainder of the warrant term.
(4) The Reporting Person disclaims beneficial ownership interest of such securities.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.